DexCom (DXCM): цена, график котировок, дивиденды, анализ, прогноз, новости

DexCom NASDAQ

DXCM

$124.34 -13.67 -10.99%

Цена за акцию на сегодня

США

Сектор: Здравоохранение Отрасль: Медицинское оборудование и принадлежности

Получите доступ
к рейтингу акций Finrange

С этим тарифом вы сможете пользоваться сервисом без ограничений, вся информация будет доступна

Получить 7 дней бесплатно

51.81B

53.70B

0.74

416.70M

0.20 %

Показатель	Компания	Отрасль
P/E (LTM) Показывает за сколько лет при прибыли за последние 12 месяцев окупятся вложения инвестора в компанию. Подробнее	81.05	53.32
P/BV (LTM) Показывает отношение рыночной цены акции к текущей балансовой стоимости. Подробнее	25.05	17.34
EV/EBITDA (LTM) Представляет собой отношение стоимости компании к полученной ею прибыли до уплаты налогов EBITDA за последние 12 месяцев. Подробнее	63.29	38.59
Net Debt/EBITDA (LTM) Коэффициент долговой нагрузки компании, который показывает, как долго компании потребуется работать при денежном потоке за последние 12 месяцев, чтобы погасить собственный долг. Подробнее	2.23	0.82
ROE (LTM) Показывает эффективность использования акционерного капитала компанией. Другими словами, ROE показывает сколько чистой прибыли за последние 12 месяцев приносит компания на вложенный капитал. Подробнее	28.45	18.14

305.63$ 579.00$

Мин Макс

Получите доступ
к рейтингу акций Finrange

С этим тарифом вы сможете пользоваться сервисом без ограничений, вся информация будет доступна

Получить 7 дней бесплатно

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company offers its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom G7, a next generation G7 CGM system; and Dexcom Share, a remote monitoring system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop next-generation CGM products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California.

Адрес:

6340 Sequence Drive, San Diego, CA, United States, 92121

Название компании:

DexCom

Тикер эмитента: DXCM

ISIN: US2521311074

Страна: США

Биржа: NASDAQ

Валюта: $

Дата IPO: 2005-04-14

Сектор: Здравоохранение

Отрасль: Медицинское оборудование и принадлежности

Сайт:

https://www.dexcom.com

On which stock exchange are DexCom (DXCM) stocks traded?

DexCom (DXCM) stocks are traded on NASDAQ.

What is the ticker of DexCom stocks (DXCM)?

The stock ticker of DexCom’s stocks or in other words, the code is DXCM. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does DexCom (DXCM) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, DexCom (DXCM) belongs to the «Здравоохранение» sector and the «Медицинское оборудование и принадлежности» industry.

In what currency are DexCom (DXCM) stocks traded?

DexCom (DXCM) stocks are traded on the NASDAQ exchange in dollars.

What is the price of DexCom (DXCM) stocks today?

The current price of DexCom stocks on 29.04.2024 is 124.34 dollars. per share.

What is the dynamics of DexCom (DXCM) stocks from the beginning of the year?

DexCom (DXCM) quotes have increased by 1.02% from the beginning of the year up to 124.34 dollars. per 1 stocks.

How much did DexCom (DXCM) stocks increase in апреле 2024?

This month DexCom (DXCM) quotes have increased by -9.86% to 124.34 dollars. per share.

How much are DexCom (DXCM) stocks worth?

Today, on October, 29.04.2024 DexCom’s (DXCM) stocks cost 124.34 dollars..

What is the market capitalization of DexCom (DXCM)?

Capitalization is the market value of DexCom (DXCM) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 29.04.2024, the market capitalization of DexCom (DXCM) is estimated at about 51812478000 dollars.

График котировок акций DexCom

Фундаментальный анализ DexCom

Изменение цены DexCom за год

Сводный анализ DexCom

Структура акционеров DexCom

Выручка и чистая прибыль DexCom

Tandem Diabetes Care Shares Rise 7% on Technology Integration With Dexcom

Tandem Diabetes Care Shares Rise 7% on Technology Integration With Dexcom

Dexcom Stock Soars on Earnings. Ozempic Isn't the Threat It Was Supposed to Be

Amazon, Intel, Ford, Enphase, Dexcom, Deckers, Exxon, Chevron, and More Stock Market Movers

Amazon, Intel, Ford, Enphase, Dexcom, Deckers, Exxon, Chevron, and More Stock Market Movers

Glucose monitor maker DexCom’s stock soars after big earnings beat, raised revenue outlook as real-time monitoring awareness grows

DexCom 3Q Profit Jumps Amid New Customer Additions

DexCom 3Q Profit Jumps Amid New Customer Additions

DexCom Stock Has Been Hit Hard By Ozempic Fears. Why They’re Overblown.

Best Buy to Sell Dexcom's Continuous Glucose Monitoring Systems

Best Buy to Sell Dexcom's Continuous Glucose Monitoring Systems

Premarket Movers: Healthcare Realty Trust, DexCom, Tesla

DexCom Shares Up 4% After FDA Approval of Continuous Glucose Monitoring System